WebApr 10, 2024 · Company Profile NVAX. Business Description. Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel ... WebMar 16, 2024 · Company Profile Novavax Inc. 21 Firstfield Road Gaithersburg, Maryland 20878 Phone 1 240 268-2000 Industry Pharmaceuticals Sector Health Care/Life Sciences Fiscal Year-end 12/2024 Revenue...
Novavax - Crunchbase Company Profile & Funding
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2024, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other … See more In June 2013, Novavax acquired the Matrix-M adjuvant platform with the purchase of Swedish company Isconova AB and renamed its new subsidiary Novavax AB. ResVax See more Vaccine research and development In January 2024, Novavax announced development of a vaccine candidate, named NVX-CoV2373, to establish immunity to SARS-CoV-2. NVX-CoV2373 is a protein subunit vaccine that contains the spike protein of the … See more Novavax is financed by both public and private investors, of which approximately 50% of the free float shares are held by institutional investors See more Novavax also develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly-owned Swedish subsidiary, … See more • Official website • Business data for Novavax, Inc.: See more WebMar 16, 2024 · Novavax is a medium health care company with 791 employees and an annual revenue of $1.1B that is headquartered in Gaithersburg, MD. The Organization’s Mission We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent … motor use in electric vehicles
Novavax
WebNovavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. Corporate Governance Novavax, Inc.’s ISS Governance QualityScore as of April 1, 2024 is … WebSee the company profile for Novavax, Inc. (NVV1.F) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ... Web2 days ago · According to Statista, global revenue from the coronavirus vaccine is expected to reach $26 billion next year. Let’s say that Novavax gets 15% of that revenue. That equates to $3.9 billion. Meanwhile, revenue from flu vaccines came in at $4.28 billion in 2024. Let’s say the market grows to $4.5 billion next year, and Novavax gets 10% of ... moto rush gt豪华版